Clinical trial
Intranasal Mupirocin to Eliminate Carriage of Staphylococcus Aureus in HIV Infection
NCT00801879 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal Mupirocin to Eliminate Carriage of Staphylococcus Aureus in HIV Infection
- Lead sponsor
- Columbia University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- April 30, 2006
- Enrollment
- 100 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, staphylococcus aureus